Rebate Monitor logo

Rebate Monitor

by Pharmaceutical Strategies Grouppsgconsults.com
VISIT OFFICIAL WEBSITE →

OVERVIEW

A web-based solution for health plans to independently monitor, validate, and reconcile pharmaceutical rebate guarantees against PBM performance.

Rebate Monitor is a robust, web-based tool that is part of Pharmaceutical Strategies Group's (PSG) Artemetrx platform, designed to provide independent and continuous oversight of Pharmacy Benefit Manager (PBM) rebate performance. It is specifically built to protect the financial interests of health plans, large employers, and health systems by accelerating the identification and resolution of variances between expected and received rebates.

The software operates by meticulously codifying a client's unique PBM contract terms, conditions, and guarantees into configurable rules. It then applies these rules to monthly pharmacy claims data to project expected rebates.

Key Features and Capabilities

  • Independent Rebate Calculation: Provides independent interpretation and calculation of expected rebates by channel, shifting the paradigm from reactive auditing to proactive oversight.
  • Near Real-Time Variance Reporting: Offers detailed variance reporting between the projected and actual rebates paid by the PBM, allowing for swift identification of discrepancies down to the claim level.
  • Data Ingestion & Updates: Features monthly claims ingestion and projection of expected rebates, with quarterly ingestion of PBM actual data.
  • Dashboards and Reports: Provides powerful filtering, drill-downs, and comprehensive dashboards to quickly identify underperforming rebates by channel or formulary.
  • Contract Rule Configuration: Transforms complex PBM contract terms into configurable rules applied to actual claims data for precision and accuracy.
  • Group-Level Comparison: Enables comprehensive group-level comparisons of expected versus paid rebates, including analysis of plan/group contract terms and guarantees.

Target Users and Use Cases

The primary target users are pharmacy leaders and finance teams within Health Plans, Health Systems, and Large Employers who manage significant pharmacy spend.

Primary Use Cases:

  1. PBM Rebate Oversight and Validation: Ensuring the PBM is adhering to all contractual rebate guarantees.
  2. Maximizing Financial Returns: Identifying unpaid rebates and preventing lost interest income by addressing discrepancies early.
  3. Financial Forecasting: Providing accurate projections of expected rebates based on claims data.

RATING & STATS

Customers
300+
Founded
2021

KEY FEATURES

  • Independent rebate calculation and projection
  • Detailed variance reporting (projected vs. actual)
  • Monthly claims ingestion and data updates
  • Configurable rules based on contract terms
  • Group-level rebate comparisons
  • Web-based dashboards and reports
  • Specialty drug rebate tracking

PRICING

Model: enterprise
Pricing is not publicly disclosed. It is an enterprise solution typically offered as a component of the broader Artemetrx platform for health plans, employers, and health systems.

TECHNICAL DETAILS

Deployment: cloud, saas
Platforms: web

USE CASES

PBM Rebate Oversight and ValidationMaximizing Rebate Financial ReturnsIdentifying Contractual DiscrepanciesFinancial Forecasting and ReportingSpecialty Drug Cost Management

COMPLIANCE & SECURITY

Compliance:
HIPAA
Security Features:
  • 🔒Encryption (Data in Transit and at Rest)
  • 🔒Access Control
  • 🔒Audit Trails

SUPPORT & IMPLEMENTATION

Support: email, phone, consulting
Implementation Time: 1-3 months
Target Company Size: medium, enterprise
TRAINING AVAILABLE

PROS & CONS

✓ Pros:
  • +Independent and proactive PBM oversight
  • +Near real-time identification of rebate variances
  • +Transforms complex contracts into configurable rules for precision
  • +Part of a broader integrated drug management platform (Artemetrx)
✗ Cons:
  • -Pricing is not publicly available (Enterprise model)
  • -No public customer reviews or ratings available
  • -Requires implementation and data integration

ABOUT PHARMACEUTICAL STRATEGIES GROUP